Wave Life Sciences Ltd.
WVE
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.2B
Close$
$0.17
96.7% downside
Current Fair Value
96.7% downsideOvervalued by 96.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.20 Billion |
|---|---|
| Enterprise Value | $886.28 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.21 |
| Beta | -1.3 |
| Outstanding Shares | 202,098,901 |
Return
| Return on Equity | -44.64% |
|---|---|
| Return on Assets | -35.85% |
| Return on Invested Capital | -42.92% |
Valuation & Multiples
| P/E Ratio | -5.6 |
|---|---|
| PEG | -14.96 |
| Price to Sales | - |
| Price to Book Ratio | 2.6 |
| Enterprise Value to Revenue | 13.56 |
| Enterprise Value to EBIT | -4.18 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
$-0.30
Average shareholder expectationRevenue Estimate
$7.45 M
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-0.34
Average shareholder expectationRevenue Estimate
$4.71 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1987▼ 11.60% |
|---|---|
| Total Calls | 47,300▼ 98.71% |
| Total Puts | 9,400▼ 99.18% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 16.44%▼ 79.42% |
|---|---|
| Total Invested | $191.24M▼ 84.72% |
| Investors Holding | 82▼ 171.00% |
ESG Score
No data
About Wave Life Sciences Ltd.
CEO: Paul Bolno